The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Incorporating CA19-9 testing in a prospective study of pancreatic cancer surveillance (PCS) among high-risk individuals (HRIs).
 
Asaf Maoz
Research Funding - Novartis (Inst)
Patents, Royalties, Other Intellectual Property - Patent applications related to macrophage-based cancer immunotherapy
 
Leah Biller
No Relationships to Disclose
 
Alyson Caruso
No Relationships to Disclose
 
Chinedu Ukaegbu
No Relationships to Disclose
 
Samantha Kuney
No Relationships to Disclose
 
Miki Horiguchi
No Relationships to Disclose
 
Isabelle Flaherty
No Relationships to Disclose
 
Lauren Brais
No Relationships to Disclose
 
Vidya Madineedi
No Relationships to Disclose
 
Benjamin MacKinnon
No Relationships to Disclose
 
Emy Abou Sleiman
No Relationships to Disclose
 
James Eshleman
Patents, Royalties, Other Intellectual Property - Patent application (Inst); Patent application (Inst)
 
Michael Goggins
No Relationships to Disclose
 
Brian Wolpin
Consulting or Advisory Role - Agenus; BeiGene; Bristol Myers Squibb Foundation; EcoR1 Capital; Harbinger Health; Immuneering; Ipsen; Mirati Therapeutics; Revolution Medicines; Takeda; Tango Therapeutics; Third Rock Ventures
Research Funding - Agios; Amgen (Inst); AstraZeneca (Inst); Harbinger Health (Inst); Lilly (Inst); Novartis (Inst); Revolution Medicines (Inst)
 
Sapna Syngal
Consulting or Advisory Role - Natera
Research Funding - Biological Dynamics
Patents, Royalties, Other Intellectual Property - Dana-Farber Cancer Institute has a registered service mark for the PREMM5 model and holds copyrights for the PREMM questionnaires (Inst); Myriad Genetics (through Dana-Farber Cancer Institute) paid an inventor share of the IP (license issue fee)
Expert Testimony - GlaxoSmithKline
(OPTIONAL) Uncompensated Relationships - Pancreatic Cancer Action Network
 
Michael Rosenthal
Consulting or Advisory Role - Merck
 
Matthew Yurgelun
Honoraria - UpToDate
Consulting or Advisory Role - Myriad Genetics; Nouscom
Research Funding - Janssen Oncology
Other Relationship - UpToDate